Managing Director & Senior Partner; Chairman, Central & Eastern Europe and Middle East
München
Christoph Schweizer is the chairman of Central and Eastern Europe and the Middle East at Boston Consulting Group. He is also a member of the firm's Executive Committee.
Christoph joined BCG in 1997, first in Munich, and then New York from 2008 to 2012. Prior to his current role, he served as the chairman of BCG’s global practices and oversaw the firm’s large-scale change initiatives: transformation, enablement, and postmerger integration. He was previously global leader of the Health Care practice.
Christoph continues to work with a broad range of companies in the health care industry, covering sectors such as medical equipment and devices, in-vitro diagnostics, pharmaceuticals, hospitals, and clinical labs. His client engagements have focused primarily on strategy, innovation, sales, marketing, M&A, and integration.
Multiple scenarios for the US and four EU countries point to a continued need for COVID-19 testing through 2024, with demand peaking in the seasonally affected first quarters of 2021 and 2022.
Globalization isn’t dying; it’s changing. Companies that base their strategies on an outdated narrative risk missing some of the world’s biggest growth opportunities.
Medtech has been a late bloomer in emerging markets, but as demand for health care in these regions increases, local medtech companies are positioned for success.
